- Report
- January 2023
- 50 Pages
China
From €2640EUR$3,000USD£2,299GBP
- Report
- December 2022
- 51 Pages
Global
€2365EUR$2,782USD£1,990GBP
- Report
- August 2022
- 81 Pages
North America
€1533EUR$1,804USD£1,290GBP
- Report
- March 2022
- 54 Pages
Global
€1584EUR$1,800USD£1,379GBP
- Report
- March 2022
- 88 Pages
Global
€3168EUR$3,600USD£2,758GBP
- Report
- February 2022
- 151 Pages
South Africa
From €2200EUR$2,500USD£1,916GBP
- Report
- January 2022
- 37 Pages
United States
- Report
- January 2022
- 278 Pages
Global
From €3179EUR$3,613USD£2,768GBP
€3740EUR$4,250USD£3,256GBP
- Report
- January 2022
- 278 Pages
Global
From €3179EUR$3,613USD£2,768GBP
€3740EUR$4,250USD£3,256GBP
- Report
- January 2022
- 14 Pages
Europe
- Report
- July 2021
- 50 Pages
China
From €2288EUR$2,600USD£1,992GBP
- Report
- April 2021
- 50 Pages
China
From €2288EUR$2,600USD£1,992GBP
- Report
- December 2020
- 63 Pages
Germany
From €535EUR$629USD£450GBP
- Report
- December 2020
- 200 Pages
Global
€3916EUR$4,450USD£3,410GBP
- Report
- August 2019
- 30 Pages
China
From €1936EUR$2,200USD£1,686GBP
- Report
- July 2019
- 26 Pages
China
- Book
- April 2019
- 836 Pages
Canada
- Training
- 120 Minutes
Global
- Training
- 60 Minutes
Global
- Report
- April 2026
Global
From €3511EUR$3,990USD£3,057GBP
The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more
